No. While it’s designed to empower patients, it’s also a resource for clinicians, researchers, and journalists.

Yes. Your privacy is important. Your email will only be used to send you the report and relevant updates. You can unsubscribe at any time.

This report is for anyone affected by or interested in the long-term effects of gadolinium-based MRI contrast agents, including patients, caregivers, healthcare professionals, researchers, and journalists.

You’ll find a summary of the largest patient-led survey to date, including patterns of symptoms, patient experiences, expert commentary, and resources for further support and research.

No, the report is for informational purposes only. It shares patient experiences and emerging patterns but does not offer medical advice or replace consultation with a qualified healthcare professional.

The survey was organised by patients and advocates, collecting responses from over 300 individuals, including those with laboratory-confirmed gadolinium retention. The methodology and limitations are explained in the report.

Absolutely. We encourage you to share the report with healthcare providers, support groups, or anyone who may benefit from this information.

If you have new or concerning symptoms after an MRI with contrast, consult your healthcare provider. You may also find resources and support groups listed in the report helpful. Additionally, I offer free clarity calls, if you'd like to talk with me directly, and you'll find more information about gadolinium contrasts and other health matters in my blog posts.

Yes! We welcome new voices and experiences. Join our mailing list for updates on future surveys and opportunities to contribute.

No, this report is observational and cannot, on its own, establish causation. Instead, it is hypothesis-generating—meaning it identifies patterns and associations that suggest a possible link between gadolinium-based contrast agents and the symptoms reported by patients. When considered alongside other scientific research on gadolinium toxicity, these findings contribute to the broader body of evidence used in frameworks like the Bradford Hill Criteria, which help evaluate whether a causal relationship exists. Importantly, our survey highlights urgent areas where more research is needed, as the signals we found suggest that many patients could be experiencing harm from contrast agents without adequate recognition or support. This underscores the need for further investigation and greater awareness among clinicians and regulators.

There are growing online communities, patient advocacy groups, and support forums dedicated to those experiencing symptoms after gadolinium-based contrast MRIs. You are not alone, and support is available.

If you believe you may be experiencing symptoms related to gadolinium-based contrast agents, you don’t have to navigate this alone. I offer free clarity calls over video to help you get clear on your next steps and discuss your concerns in a supportive, understanding environment. You’ll also find a wealth of articles and resources about gadolinium contrasts and related health topics on my website. For ongoing support and updates, you can connect with me on Facebook as The Food Phoenix. I’m here to listen, share information, and help you move forward.